Urinary prostate-specific antigen is a noninvasive indicator of sexual development in male children

Journal of Andrology

Volumn 28, Issue 1, 2007, Pages 150-154

  Sato, Itaru ^a,b   Yoshikawa, Atsuko ^c,e   Fugimoto, Masatoshi ^b   Shimizu, Keiko ^d   Ishiwari, Atsuya ^c   Mukai, Toshiji ^b   Iwamoto, Teruaki ^b  

^a Scientific Crime Laboratory   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c THE UNIVERSITY OF TOKYO   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Infant; Puberty; Urine

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; MALE; NORMAL HUMAN; PREMATURITY; PRIORITY JOURNAL; PUBERTY; SEXUAL DEVELOPMENT; URINALYSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PROSTATE-SPECIFIC ANTIGEN; SEXUAL DEVELOPMENT; TESTOSTERONE;

EID: 33846013229     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.2164/jandrol.106.000190     Document Type: Article

References (19)

1. Barrett GM, Shimizu K, Bardi M, Mori A. Fecal testosterone immunoreactivity as a non-invasive index of functional testosterone dynamics in male Japanese macaques (Macaca fuscata). Primates. 2002;43:29-39.
2. Brown GR, Nevison CM, Fraser HM, Dixson AF. Manipulation of postnatal testosterone levels affects phallic and clitoral development in infant rhesus monkeys. Int J Androl. 1999;22:119-128.
3. Forest MG, Sizonenko PC, Cathiard AM, Bertrand J. Hypophysogonadal function in humans during the first year of life. J Clin Invest. 1974;53:819-828.
4. Goldfarb DA, Stein BS, Shamszadeh M, Petersen RO. Age-related changes in tissue levels of prostatic acid phosphatase and prostate specific antigen. J Urol. 1986;136:1266-1269.
5. Huhtanieme I, Dunkel L, Perheentupa J. Transient increase in postnatal testicular activity is not revealed by longitudinal measurements of salivary testosterone. Pediatric Res. 1986;20: 1324-1327.
6. Irani J, Millet C, Levillain P, Doré B, Begon F, Aubert J. Serum-to-urinary prostate-specific antigen ratio: a potential means of distinguishing benign prostatic hyperplasia from prostate cancer. Eur Urol. 1996;29:407-412.
7. Irani J, Millet C, Levillain P, Doré B, Begon F, Aubert J. Serum-to-urinary prostate specific antigen ratio: its impact in distinguishing prostate cancer when serum prostate specific antigen level is 4 to 10 ng./ml. J Urol. 1997;157:185-188.
8. Irani J, Salomon L, Soulie M, Zlotta A, de la Taille A, Doré B, Millet C. Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer. Urology. 2005;65:533-537.
9. Juul A, Müller J, Skakkebæk NE. Prostate specific antigen in boys with precocious puberty before and during gonadal suppression by GnRH agonist treatment. Eur J Endcrinol. 1997;136:401-405.
10. Kim MR, Gupta MK, Travers SH, Rogers DG, Van Lente F, Faiman C. Serum prostate specific antigen, sex hormone binding globulin and free androgen index as markers of pubertal development in boys. Clin Endocrinol. 1999;50:203-210.
11. Mann DR, Akinbami MA, Gould KG, Tanner JM, Wallen K. Neonatal treatment of male monkeys with a gonadotropin-releasing hormone agonist alters differentiation of central nervous system centers that regulate sexual and skeketal development. J Clin Endocrinol Metab. 1993;76:1319-1324.
12. Mann DR, Fraser HM. The neonatal period: a critical interval in male primate development. J Endocrinol. 1996;149:191-197.
13. Mann DR, Gould KG, Collins DC, Wallen K. Blockade of neonatal activation of the pituitary-testicular axis: effect on prepubertal luteinzing hormone and testosterone secretion and testicular development in male monkeys. J Clin Endocrinol Metab. 1989;68: 600-607.
14. Randell EW, Diamandis EP, Ellis G. Serum prostate-specific antigen measured in children from birth to age 18 years. Clin Chem. 1996;42:420-423.
15. Rosenfield RL. Clinical review 6: diagnosis and management of delayed puberty. J Clin Endocrinol Metab. 1990;70:559-562.
16. Sato I, Sagi M, Ishiwari A, Nishijima H, Ito E, Mukai T. Use of the "SMITEST" PSA card to identify the presence of prostate-specific antigen in semen and male urine. Forensic Sci Int. 2002;127:71-74.
17. Stamey TA, Kabalin JN, Ferrari M, Yang N. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients. J Urol. 1989;141:1088-1090.
18. Vieira JGH, Nishida SK, Pereira AB, Pereira AB, Arraes RF, Verreschi ITN. Serum levels of prostate-specific antigen in normal boys through puberty. J Clin Endocrinol Metab. 1994;78:1185-1187.
19. Wallen K, Maestripieri D, Mann DR. Effects of neonatal testicular suppression with a GnRH antagonist on social behavior in group-living juvenile rhesus monkeys. Horm Behav. 1995;29:322-337.